Literature DB >> 11495618

Risk factors for meningococcal disease in college students.

M G Bruce1, N E Rosenstein, J M Capparella, K A Shutt, B A Perkins, M Collins.   

Abstract

CONTEXT: Elevated rates of meningococcal disease were noted among 18- to 22-year-olds in the mid-1990s. However, national data on rates of meningococcal disease in US college students were not collected until 1998.
OBJECTIVES: To determine rates of meningococcal disease in US college students and to identify risk factors for meningococcal disease in this population. DESIGN, SETTING, AND PATIENTS: Prospective surveillance study with nested case-control study of US college students with meningococcal infection from September 1, 1998, to August 31, 1999. Fifty state health departments and 231 college health centers participated. MAIN OUTCOME MEASURES: Incidence of and risk factors for meningococcal disease in US college students.
RESULTS: Ninety-six cases of meningococcal disease were identified. The incidence rate for undergraduates was 0.7 per 100 000 persons vs 1.4 per 100 000 for the general population of 18- to 23-year-old nonstudents (P<.001). Freshmen living in dormitories had the highest incidence rate at 5.1 per 100 000. Of the 79 case-patients for whom information was available, 54 (68%) had illness due to vaccine-preventable meningococcal serogroups. On multivariable analysis of case-control study data, freshmen who lived in dormitories had an elevated risk of meningococcal disease (matched odds ratio, 3.6; 95% confidence interval, 1.6-8.5; P =.003) compared with other college students.
CONCLUSIONS: Freshmen who live in dormitories have an independent, elevated risk of meningococcal disease compared with other college students. Use of the currently available quadrivalent polysaccharide vaccine among college students could substantially decrease their risk of meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495618     DOI: 10.1001/jama.286.6.688

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  42 in total

Review 1.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students.

Authors:  J D Holmes; D Martin; C Ramsay; E Ypma; P Oster
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

5.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

Review 6.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

7.  First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak.

Authors:  Lucy A McNamara; Alice M Shumate; Peter Johnsen; Jessica R MacNeil; Manisha Patel; Tina Bhavsar; Amanda C Cohn; Jill Dinitz-Sklar; Jonathan Duffy; Janet Finnie; Denise Garon; Robert Hary; Fang Hu; Hajime Kamiya; Hye-Joo Kim; John Kolligian; Janet Neglia; Judith Oakley; Jacqueline Wagner; Kathy Wagner; Xin Wang; Yon Yu; Barbara Montana; Christina Tan; Robin Izzo; Thomas A Clark
Journal:  Pediatrics       Date:  2015-05       Impact factor: 7.124

Review 8.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Should university students be vaccinated against meningococcal disease in Canada?

Authors:  Philippe De Wals
Journal:  Can J Infect Dis       Date:  2004-01

10.  Risk and prevention of meningococcal disease among education workers: A review.

Authors:  Philippe De Wals; Pierre Deshaies; Gaston De Serres; Bernard Duval; Lise Goulet; Bernard Pouliot; Sylvie Ricard; Maurice Poulin
Journal:  Can J Infect Dis       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.